Adial Pharmaceuticals Inc

NASDAQ: ADILHealthcare / Biotechnology / USA
1.6800.00Vol 2 4581Y Perf -54.72%
Aug 21st, 2019 16:00
BID1.62 ASK1.68
Open1.60 Previous Close1.68
Pre-Market- After-Trading-
 - -%  - -%
Target Price
5.50 
Analyst Rating
Strong Buy 1.00
Potencial %
227.38 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12M
-/100/100 
Value Ranking
 —    -
Insiders Value % 3/6/12M
-/100/100 
Growth Ranking
 —    -
Insiders Shares Cnt. % 3/6/12M
-/100/100 
Income Ranking
 —    -
Market Cap (mil)17 
Earnings Rating
Neutral
Price Range Ratio 52wk %
6.84 
Earnings Date
6th Sep 2019

Today's Price Range

1.601.68

52wk Range

1.119.44

Summary:

Buy

Technical Indicators: Neutral
Moving Averages: Strong Buy
Performance
1 Week
15.07%
1 Month
-14.72%
3 Months
-23.98%
6 Months
-56.14%
1 Year
-54.72%
3 Years
-
5 Years
-
10 Years
-

Name / TickerPriceChg.Chg.%
ADIL1.680.00000.00
AAPL212.642.28001.08
GOOG1 191.258.56000.72
MSFT138.791.53001.11
XOM69.720.69001.00
WFC45.000.32000.72
JNJ131.530.93000.71
FB183.55-0.2600-0.14
GE8.16-0.2200-2.63
JPM107.610.30000.28
Earnings HistoryEstimateReportedSurprise %
Q01 2019--0.33-
Q03 2018-0.31-0.85-174.19
----
----
----
----
----
----
Earnings Per EndEstimateRevision %Trend
12/2019 FY-1.000.00-
----
----
----
Next Report Date6th Sep 2019
Estimated EPS Next Report-
Estimates Count-
EPS Growth Next 5 Years %-
Volume Overview
Volume2 458
Shares Outstanding (in ths.)10 242
Trades Count61
Dollar Volume29 319
Avg. Volume251 706
Avg. Weekly Volume21 501
Avg. Monthly Volume31 840
Avg. Quarterly Volume43 506
Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
2 (100.00 %)
2 (100.00 %)
2 (100.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
RatingStrong Buy
1.00
Strong Buy
1.00
Strong Buy
1.00

Adial Pharmaceuticals Inc

Adial Pharmaceuticals Inc is a United States-based pharmaceutical company. The company develops prescription medications for addiction and related disorders. Its lead product is AD04, which is an approved drug for treating nausea and emesis.

CEO: William B. Stilley

Teplephone: +1 434 422-9800

Address: 1001 Research Park Boulevard, Charlottesville 22911, VA, USA

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

44%56%

Bearish Bullish

60%40%

Bearish Bullish

42%58%

News